Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 363

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review

Open access
Mahajan, Rahul, Sahoo, AlokKumar·2016·Indian Dermatology Online Journal
DOI 10.4103/2229-5178.178099
Open this paper in CoChat — free account

Abstract

The prevalence of superficial mycotic infection worldwide is 20-25% of which dermatophytes are the most common agents. Recent developments in understanding the pathophysiology of dermatophytosis have confirmed the central role of cell-mediated immunity in countering these infections. Hence, a lack of delayed hypersensitivity reaction in presence of a positive immediate hypersensitivity (IH) response to trichophytin antigen points toward the chronicity of disease. Diagnosis, though essentially clinical should be confirmed by laboratory-based investigations. Several new techniques such as polymerase chain reaction (PCR) and mass spectroscopy can help to identify the different dermatophyte strains. Management involves the use of topical antifungals in limited disease, and oral therapy is usually reserved for more extensive cases. The last few years have seen a significant rise in the incidence of chronic dermatophyte infections of skin which have proven difficult to treat. However, due to the lack of updated national or international guidelines on the management of tinea corporis, cruris, and pedis, treatment with systemic antifungals is often empirical. The present review aims to revisit this important topic and will detail the recent advances in the pathophysiology and management of tinea corporis, tinea cruris, and tinea pedia while highlighting the lack of clarity of certain management issues.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4103/2229-5178.178099

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Research works printed but not linked: 42

  1. Fuller, 2014, British Association of Dermatologists' guidelines for the management of tinea capitis 2014, Br J Dermatol, 454
  2. Sharma, 2012, Clinico-mycological evaluation of dermatophytes and non-dermatophytes isolated from various clinical samples: A study from north India, J Res Med Sci, 817
  3. Agarwal, 2014, Clinico-mycological study of dermatophytes in a tertiary care centre in Northwest India, Indian J Dermatol Venereol Leprol, 194
  4. Sahai, 2011, Change in spectrum of dermatophytes isolated from superficial mycoses cases:First report from Central India, Indian J Dermatol Venereol Leprol, 335
  5. Jaradat, 2015, Low DEFB4 copy number and high systemic hBD-2 and IL-22 levels are associated with dermatophytosis, J Invest Dermatol, 750
  6. Dahl, 1994, Dermatophytosis and the immune response, J Am Acad Dermatol, S34
  7. Jones, 1974, Immunologic susceptibility to chronic dermatophytosis, Arch Dermatol, 213
  8. Kurade, 2006, Skin scraping and a potassium hydroxide mount, Indian J Dermatol Venereol Leprol, 238
  9. Lasseter, 2011, Developing best practice for fungal specimen management: Audit of UK microbiology laboratories, Br J Biomed Sci, 197
  10. Singh, 2007, Evaluation of microdilution and disk diffusion methods for antifungal susceptibility testing of dermatophytes, Med Mycol, 595
  11. Gómez-Moyano, 2010, Tinea of vellus hair: An indication for systemic antifungal therapy, Br J Dermatol, 603
  12. Yang, 2007, Direct identification of dermatophyte DNA from clinical specimens by a nested polymerase chain reaction assay, Arch Dermatol, 799
  13. Hui, 2013, Evaluation of reflectance confocal microscopy in dermatophytosis, Mycoses, 130
  14. Weinstein, 2002, Topical treatment of common superficial tinea infections, Am Fam Physician, 2095
  15. High WA, Fitzpatrick JE. Topical antifungal agents. In: Fitzpatrick's Dermatology in General Medicine. 8th ed. Tata McGraw Hill: New Delhi; 2012. p. 2116-21.
  16. Havlickova, 2008, The advantages of topical combination therapy in the treatment of inflammatory dermatomycoses, Mycoses, 16
  17. Nadalo, 2006, What is the best way to treat tinea cruris?, J Fam Pract, 256
  18. Alston, 2003, Persistent and recurrent tinea corporis in children treated with combination antifungal/corticosteroid agents, Pediatrics, 201
  19. Haedersdal, 2003, Systematic treatment of tinea pedis – Evidence for treatment.A result of a Cochrane review?, Ugeskr Laeger, 1436
  20. Stein, 2015, Naftifine hydrochloride gel 2%: An effective topical treatment for moccasin-type tinea pedis, J Drugs Dermatol, 1138
  21. Elewski, 2014, Econazole nitrate foam 1% for the treatment of tinea pedis: Results from two double-blind, vehicle-controlled, phase 3 clinical trials, J Drugs Dermatol, 803
  22. Li, 2014, Efficacy and safety of 1% terbinafine film-forming solution in Chinese patients with tinea pedis: A randomized, double-blind, placebo-controlled, multicenter, parallel-group study, Clin Drug Investig, 223
  23. Czaika, 2013, Effective treatment of tinea corporis due to Trichophyton mentagrophytes with combined isoconazole nitrate and diflucortolone valerate therapy, Mycoses, 30
  24. Bourlond, 1989, Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea corporis and tinea cruris, Int J Dermatol, 410
  25. Cole, 1989, A comparison of a new oral antifungal, terbinafine, with griseofulvin as therapy for tinea corporis, Arch Dermatol, 1537
  26. Panagiotidou, 1992, A comparison of itraconazole and griseofulvin in the treatment of tinea corporis and tinea cruris: A double-blind study, J Int Med Res, 392
  27. Shi, 2014, Combination treatment of oral terbinafine with topical terbinafine and 10% urea ointment in hyperkeratotic type tinea pedis, Mycoses, 560
  28. Wong, 2015, Antifungal mode of action of macrocarpal C extracted from Eucalyptus globulus Labill (Lan An) towards the dermatophyte Trichophyton mentagrophytes, Chin Med, 34
  29. Smith, 1991, Majocchi's granuloma, J Cutan Pathol, 28
  30. Gill, 2007, Majocchi's granuloma of the face in an immunocompetent patient, J Dermatol, 702
  31. Akiba, 2001, Recalcitrant trichophytic granuloma associated with NK-cell deficiency in a SLE patient treated with corticosteroid, Eur J Dermatol, 58
  32. Gupta, 1995, Terbinafine in the treatment of Majocchi's granuloma, Int J Dermatol, 489
  33. Feng, 2006, Majocchi's granuloma in a 3-year-old boy, Pediatr Infect Dis J, 658
  34. Ravine, 1980, Genetic inheritance of susceptibility to tinea imbricata, J Med Genet, 342
  35. Jones, 1993, Immune response and host resistance of humans to dermatophyte infection, J Am Acad Dermatol, S12
  36. Hay, 1983, Immune responses of patients with tinea imbricata, Br J Dermatol, 581
  37. Verma, 2015, Topical steroid-induced tinea pseudoimbricata: A striking form of tinea incognito, Int J Dermatol, e192
  38. Millikan, 2001, Role of oral antifungal agents for the treatment of superficial fungal infections in immunocompromised patients, Cutis, 6
  39. Elston, 2013, Treatment of common skin infections and infestations during pregnancy, Dermatol Ther, 312
  40. Piñeiro, 2010, Trichophyton rubrum syndrome: The tip of the iceberg and a preventable outcome, Mycoses, 186
  41. Ghannoum, 2006, Voriconazole susceptibilities of dermatophyte isolates obtained from a worldwide tinea capitis clinical trial, J Clin Microbiol, 2579
  42. Ghannoum, 2008, Susceptibility of dermatophyte isolates obtained from a large worldwide terbinafine tinea capitis clinical trial, Br J Dermatol, 711

Cited by

See all 363

Metadata

Authors
Mahajan, R., & Sahoo, A.
Venue
Indian Dermatology Online Journal
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2016
Volume
7
Issue
2
Pages
77
ISSN
2229-5178 (ISSN-L)
DOI
10.4103/2229-5178.178099
OpenAlex
W2291064259
Cited by
363
References
32
FWCI
19.35
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review. https://app.cochat.ai/papers/10.4103/2229-5178.178099
The paper
Mahajan, R., & Sahoo, A. (2016). Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review. Indian Dermatology Online Journal. https://doi.org/10.4103/2229-5178.178099

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.